Medicare Compliance & Reimbursement - 2005 Issue 9
Studies & Surveys: Chemo Reimbursement Not Covering $144 Million Cost
Subscribe or sign in to view the full article.
Article Overview
This piece reports on research concerning oncology practice costs and Medicare reimbursement, with emphasis on chemotherapy administration payments, practice expense comparisons, and how payment methodology affects oncology clinics. It is relevant to oncology administrators, billing professionals, and healthcare finance stakeholders interested in reimbursement policy and specialty practice costs. The article also references studies commissioned by advocacy organizations and presented to federal payment officials.
Why This Topic Matters
Understanding the gap between oncology practice expenses and reimbursement helps practices assess financial pressure, monitor payment policy impacts, and evaluate broader Medicare reimbursement trends affecting chemotherapy services.
What You Will Learn
- How study findings describe reimbursement levels relative to oncology practice expenses
- What the article says about chemotherapy-related preparation costs and aggregate annual impact
- Which organizations and research groups were involved in the studies discussed
- Why Medicare payment methodology is presented as relevant to specialty practice reimbursement
Who Should Read This
- Oncology practice managers
- Medical coders and billers
- Healthcare reimbursement analysts
- Physician administrators
- Health policy professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com